Quercetin: A Light in the Fight Against MRSA

Area of Science:

• Biochemistry
• Photomedicine
• Infectious Diseases

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant global health threat due to its resistance to conventional antibiotics.
• Antimicrobial photodynamic therapy (aPDT) is an emerging treatment modality for bacterial infections.
• Natural compounds are being investigated as photosensitizers for aPDT due to their potential for reduced toxicity and side effects.

Purpose of the Study:

• To investigate the efficacy of quercetin as a photosensitizer for aPDT against MRSA.
• To evaluate the antimicrobial activity, cytotoxicity, and anti-inflammatory potential of quercetin-mediated aPDT.
• To assess the impact of quercetin-mediated aPDT on bacterial load and host immune response in a preclinical MRSA infection model.

Main Methods:

• In vitro cytotoxicity and antibacterial assays of quercetin photoactivated with blue LED light.
• In vivo intradermal MRSA infection model in BALB/c mice.
• Assessment of bacterial load in lymph nodes, polymorphonuclear cell recruitment, and cytokine production (IL-12, TNF-α).

Main Results:

• Quercetin exhibited low cytotoxicity and significant antibacterial activity in vitro, associated with singlet oxygen generation.
• Quercetin-mediated aPDT treatment in mice led to a reduced MRSA bacterial load in draining lymph nodes.
• Reduced polymorphonuclear cell recruitment and modulation of IL-12 and TNF-α cytokine interactions were observed in treated mice.

Conclusions:

• Quercetin is a potential photosensitizer for aPDT against MRSA infections.
• Quercetin demonstrates both antimicrobial and anti-inflammatory properties beneficial for treating resistant bacterial infections.
• These findings support the development of quercetin-based aPDT strategies for combating MRSA.